Lannett

United States 495 employees Updated 9 July 2026

Lannett is a finished-dose manufacturer based in United States. It appears in 189 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA and DMP (NO). Its most recent recorded inspection, by US FDA, closed on 21 October 2022 as VAI.

active US DMFs

valid CEPs

registered plants 1 with an FDA FEI number

189

filings across 2 regulators

These figures were checked against the regulators' own files on 25 July 2026

Plants

1 of 1 confirmed

Inspections

8 of 8 confirmed

Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

21 October 2022 VAI US FDA
2 February 2018 VAI US FDA
16 December 2014 VAI US FDA
15 August 2013 VAI US FDA
31 October 2012 OAI US FDA
29 August 2012 VAI US FDA
13 May 2011 VAI US FDA
12 May 2010 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site	FDA FEI
Seymour, United States	1819171

Filings and GMP by regulator

Regulator	Filings	GMP certificates
US FDA	183	None
DMP (NO)	6	None

Comparing suppliers?

Choose your molecules and target markets. Lannett comes back tiered against every other supplier able to file there.

Start for free

No sales call.

Open risk flags

18 active litigation matters are on record.
The most recent inspection outcome was VAI, on 21 October 2022.

Sources on this page

FDA: Drug master files, establishment registration, inspection classifications
EDQM: Certificates of suitability